Loading verified market, valuation, and statement data.
2. Company Fundamentals
2.1 Competitiveness
| Metric |
Value |
| Operating Margins |
25.44% |
| Profit Margins |
13.41% |
| Return on Equity |
90.45% |
| Return on Assets |
9.9% |
| Free Float |
0.31B |
| Dividend Yield |
2.38% |
| Short Int % Utilisation |
10.87% |
2.2 Growth
| Metric |
Value |
| Revenue Growth |
25.3% |
| Free Cash Flow |
1.62B |
| EBITDA |
9.63 (Ratio) |
| Enterprise Value |
46.53B |
| EV/Revenue |
3.39 |
| EV/EBITDA |
9.63 |
Revenue growth of 25.3% places the company in a high-growth category.
2.3 Management
| Role |
Metric |
| Consensus Rating |
N/A |
2.4 Return
| Metric |
Value |
| Expected Return (Ann.)* |
-6.52% |
| Risk / Std Dev (Ann.)* |
34.82% |
| 1-Year Price Return* |
-11.98% |
Latest Market Data (as of 2026-08-14, US Eastern time):
| Metric |
Value |
| Last Price |
$46.23 |
| 52-Week Range |
$44.21 – $70.45 |
| Observation Count |
251 trading days |
The return and risk statistics use daily adjusted closes from the retrieved one-year series and annualise daily moments using 252 trading days. The last price is the latest regular-market price reported for the stated date. Source: Yahoo Finance market data.
2.5 FCFF DCF Valuation
Valuation basis: This research model follows a five-year, unlevered FCFF DCF. It starts from reported annual operating inputs, forecasts revenue and operating cash conversion under an explicit mechanical policy, discounts FCFF at WACC, applies a Gordon-growth terminal value, and bridges enterprise value to an indicative common-equity value per share. It is an analytical estimate rather than a recommendation or personalised target price.
Step 1 — Forecast Operating Profit and NOPAT
| Reported operating input |
Value |
| Revenue |
$13.02B |
| Prior annual revenue |
$11.30B |
| EBIT |
$2.96B |
| Tax rate |
15.70% |
| NOPAT = EBIT × (1 − tax rate) |
$2.49B |
| Forecast start-growth basis |
15.00% |
| Forecast policy |
latest reported annual revenue growth, bounded to -10.00% / 15.00% |
Step 2 — Calculate FCFF
| Current FCFF building block |
Value |
| NOPAT |
$2.49B |
| Add: depreciation & amortisation |
$1.54B |
| Less: capital expenditure |
-$1.24B |
| Less/(add): working-capital cash-flow movement |
-$784.00M |
| Current unlevered FCFF |
$2.01B |
Explicit FCFF forecast
| Forecast year |
Revenue growth |
NOPAT |
D&A |
Capex |
Change in NWC |
FCFF |
Present value |
| 1 |
15.00% |
$2.87B |
$1.77B |
-$1.43B |
-$901.60M |
$2.31B |
$2.23B |
| 2 |
11.88% |
$3.21B |
$1.98B |
-$1.69B |
-$1.01B |
$2.49B |
$2.23B |
| 3 |
8.75% |
$3.49B |
$2.15B |
-$1.95B |
-$1.10B |
$2.60B |
$2.17B |
| 4 |
5.62% |
$3.69B |
$2.28B |
-$2.17B |
-$1.16B |
$2.64B |
$2.04B |
| 5 |
2.50% |
$3.78B |
$2.33B |
-$2.33B |
-$1.19B |
$2.59B |
$1.87B |
Step 3 — Determine the Discount Rate (WACC)
| WACC input |
Value |
| Risk-free rate |
4.71% |
| Equity risk premium assumption |
5.50% |
| Beta |
0.83 |
| Cost of equity |
9.30% |
| Pre-tax cost of debt |
5.05% |
| WACC |
7.55% |
| WACC validation |
within standard range |
Step 4 — Estimate Terminal Value
| Terminal-value input |
Value |
| Perpetuity growth rate |
2.50% |
| Terminal value |
$52.56B |
| Implied terminal EV / EBITDA |
7.71x |
| Terminal value as % of enterprise value |
77.61% |
Step 5 — Discount Cash Flows to Enterprise Value
| Enterprise-value component |
Value |
| Present value of explicit FCFF |
$10.54B |
| Present value of terminal value |
$36.52B |
| Indicated enterprise value |
$47.05B |
| Discounting convention |
mid-year for explicit FCFF; terminal value discounted at year-end five |
Step 6 — Convert Enterprise Value to Equity Value
| Equity bridge |
Value |
| Indicated enterprise value |
$47.05B |
| Less: gross interest-bearing debt |
$15.78B |
| Add: cash and equivalents |
$3.84B |
| Add: affiliate investments |
$0.00 |
| Less: minority interests |
$344.00M |
| Indicated common equity value |
$34.77B |
Step 7 — Calculate Indicative Value Per Share
| Per-share output |
Value |
| Shares used |
693,000,000.00 |
| Share-count basis |
reported diluted weighted-average shares |
| Current market price |
$45.84 |
| DCF indicative value per share |
$50.17 |
| Indicative value vs. market price |
9.44% |
Model Integrity Checks
| Check |
Result |
| Perpetuity growth is below the risk-free rate |
pass |
| Perpetuity growth is below WACC |
pass |
| WACC is within the configured operating-company range |
pass |
| Terminal-year FCFF is positive |
pass |
| Terminal capex converges to D&A |
pass |
| Terminal-value concentration |
within review band |
| Implied price differs from spot by more than 30% |
within review band |
2.6 Investor-Style Research Screen
| Educational screen |
Result |
| Buffett-inspired cash-quality checks |
4/4 evidenced checks |
| Lynch-inspired balance-and-growth checks |
4/4 evidenced checks |